BRAND HOUSE COLLECTIVE, INC.
CEO, COO
2022-07-14–present
1 appearance
Latest appearance 2025-09-16
Amy Sullivan
CEO
BRAND HOUSE COLLECTIVE, INC.
COO
BRAND HOUSE COLLECTIVE, INC.
BRAND HOUSE COLLECTIVE, INC.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Amy Sullivan
Amy Sullivan is recorded as CEO and COO at BRAND HOUSE COLLECTIVE, INC. and CFO at IO Biotech, Inc. (IOBTQ). IO Biotech, Inc. reported in an 8-K filed March 31, 2026 that Amy Sullivan was terminated as Chief Financial Officer and Chief Accounting Officer, effective March 31, 2026. IO Biotech, Inc. reported in an 8-K filed March 31, 2026 that Amy Sullivan was terminated as Chief Financial Officer and Chief Accounting Officer, effective March 31, 2026. BRAND HOUSE COLLECTIVE, INC. reported in an 8-K filed January 19, 2024 that Amy Sullivan was appointed Chief Executive Officer, effective February 4, 2024. Equibles holds 6 filed executive changes naming Amy Sullivan; each is listed under recent activity with its source filing. The proxy statement of IO Biotech, Inc. reports total compensation of $998,412 for Amy Sullivan in fiscal 2024, including a base salary of $439,875. Disclosed compensation is on record for 4 fiscal years. Amy Sullivan has spoken on 1 earnings call across 1 company, most recently for BRAND HOUSE COLLECTIVE, INC. on September 16, 2025.
“Concurrently with the Petition, on March 31, 2026, the Company terminated all employees and officers without cause, including Mai-Britt Zocca, Chief Executive Officer, and Amy Sullivan, Chief Financial Officer and Chief Accounting Officer.”
“Concurrently with the Petition, on March 31, 2026, the Company terminated all employees and officers without cause, including Mai-Britt Zocca, Chief Executive Officer, and Amy Sullivan, Chief Financial Officer and Chief Accounting Officer.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
BRAND HOUSE COLLECTIVE, INC.
COO
SEC 8-K
Current2023-04-04–present
-
Current
2022-10-15–present
-
BRAND HOUSE COLLECTIVE, INC.
SEC 8-K
Current2022-07-14–present
-
BRAND HOUSE COLLECTIVE, INC.
CEO
Source not stated
Current -
Start not stated–2026-03-31
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at IO Biotech, Inc.
Other people whose current roles at this company are on record from its filings.
- Devin W. Smith General Counsel
- Heidi Hunter Board Member
- Helen Collins, M.D. Board Member
- Mai-Britt Zocca Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | IO Biotech, Inc. (IOBTQ) | M.B.A., Chief Financial Officer | $439,875 | $998,412 |
| 2024 | BRAND HOUSE COLLECTIVE, INC. | CEO | $523,558 | $1,024,683 |
| 2023 | IO Biotech, Inc. (IOBTQ) | M.B.A., Chief Financial Officer | — | — |
| 2023 | BRAND HOUSE COLLECTIVE, INC. | CEO | $438,462 | $680,831 |
| 2022 | IO Biotech, Inc. (IOBTQ) | Chief Financial Officer | $89,658 | $635,173 |
| 2022 | BRAND HOUSE COLLECTIVE, INC. | CEO | $375,000 | $531,250 |
| 2021 | IO Biotech, Inc. (IOBTQ) | Chief Financial Officer | — | — |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
-
-
-
Earnings call
BRAND HOUSE COLLECTIVE, INC. Q2 FY2026 Earnings Call
BRAND HOUSE COLLECTIVE, INC.
-
-
-
-
Executive change Appointed: Senior Vice President and Chief Merchandising & Stores Officer
BRAND HOUSE COLLECTIVE, INC.